Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

She grew weaker and decided to visit a nearby clinic to get help after returning home from a family trip. Turns out Pulane ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

Gauteng health authorities are making progress in starting RR-TB patients on treatment, but a new NICD report shows that many still face delays or are never traced after diagnosis.

By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...